Inhibrx Biosciences INBX
NASDAQ INBX
$93.47 -3.63 (-3.74%)
As of: Oct 23, 2026 · 3:54 PM EDT

Inhibrx Biosciences (INBX) Net Shares Issued and Repurchased (2023 - 2025)

Updated

Analysis

Inhibrx Biosciences (INBX) Net Shares Issued and Repurchased (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,133.26 Bn 1,101.85 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 635.92 Bn 555.78 Bn 17.30 Bn -966.00 Mn
3 AbbVie 506.32 Bn 479.44 Bn 12.70 Bn -9.00 Mn
4 Merck 358.38 Bn 312.76 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 293.00 Bn 256.99 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 265.76 Bn 239.44 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.88 Bn 193.27 Bn 7.24 Bn -
8 Gilead Sciences 195.26 Bn 169.45 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.34 Bn 117.99 Bn 10.94 Bn -
10 Inhibrx Biosciences 1.47 Bn 875.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.25 Mn
Sep 30, 2025 352,000.00
Jun 30, 2024 32.95 Mn
Mar 31, 2024 38.73 Mn
Dec 31, 2023 1.09 Mn
Sep 30, 2023 200.02 Mn
API Access

Inhibrx Biosciences Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=INBX&period=max&api_key=YOUR_API_KEY